Joshua Caldwell, MD
Urology · Seattle, WANPI 1285196188
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $5,345 of the $8,593 with a category attached, or 62.2%. 11 manufacturers reported payments, led by Intuitive Surgical at 40.4% of the total. 2025 is the largest year on record at $5,310, more than ten times the $38 reported in 2023.
Across 58 payments — averaging $148.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Angiodynamics, Inc.$3K
- Procept Biorobotics Corporation$1K
- Coloplast$555
- Boston Scientific$291
- Axonics, Inc.$76
- plus $161 from 5 others
What the payments were for
- Travel & lodging$5,34562%
- Food & beverage$1,74820%
- Education$1,50017%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 9 | $3,472 |
| Angiodynamics, Inc. | 15 | $2,694 |
| Procept Biorobotics Corporation | 13 | $1,343 |
| Coloplast | 6 | $555 |
| Boston Scientific | 8 | $291 |
| Axonics, Inc. | 2 | $76 |
| Calyxo, Inc. | 1 | $71 |
| Bayer | 1 | $28 |
| Urogen Pharma, Inc. | 1 | $23 |
| 180 Medical, Inc. | 1 | $20 |
| Cook Medical LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nanoknife$2,193
- Da Vinci Surgical System$1,814
- DAVINCI XI$1,500
- AquaBeam Robotic System$974
- ALTIS$474
- VenaCure 1470 Pro$312
How this compares
$8,593 in reported general payments places this provider in the 80th percentile of 274 urology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 43 | $24,582 |
| Solifenacin Succinate | 45 | $1,593 |
| Tamsulosin Hcl | 53 | $1,119 |
| Finasteride | 38 | $743 |
| Estradiol | 11 | $664 |
| Trospium Chloride | 18 | $369 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 25 | $341 |
| Doxazosin Mesylate | 11 | $168 |
| Ciprofloxacin Hcl | 13 | $42 |
Paid to pharmacies, not to this prescriber.
Other urology in Seattle
- James PorterSeattle$471K
- Marah HehemannSeattle$213K
- Thomas WalshSeattle$186K
- Alvaro LucioniSeattle$148K
- Una LeeSeattle$116K
- George SchadeSeattle$78K
- Vi NguyenSeattle$53K
- Rogerio HuangSeattle$45K
- Cristopher GarlitzSeattle$45K
- Sarah PsutkaSeattle$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.